1. Home
  2. BRO vs ALC Comparison

BRO vs ALC Comparison

Compare BRO & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRO
  • ALC
  • Stock Information
  • Founded
  • BRO 1939
  • ALC 1945
  • Country
  • BRO United States
  • ALC Switzerland
  • Employees
  • BRO N/A
  • ALC N/A
  • Industry
  • BRO Specialty Insurers
  • ALC Ophthalmic Goods
  • Sector
  • BRO Finance
  • ALC Health Care
  • Exchange
  • BRO Nasdaq
  • ALC Nasdaq
  • Market Cap
  • BRO 34.8B
  • ALC 41.8B
  • IPO Year
  • BRO N/A
  • ALC N/A
  • Fundamental
  • Price
  • BRO $117.22
  • ALC $92.54
  • Analyst Decision
  • BRO Buy
  • ALC Buy
  • Analyst Count
  • BRO 12
  • ALC 12
  • Target Price
  • BRO $115.92
  • ALC $105.60
  • AVG Volume (30 Days)
  • BRO 2.0M
  • ALC 2.0M
  • Earning Date
  • BRO 04-28-2025
  • ALC 05-12-2025
  • Dividend Yield
  • BRO 0.51%
  • ALC 0.37%
  • EPS Growth
  • BRO 13.44
  • ALC 4.59
  • EPS
  • BRO 3.46
  • ALC 2.05
  • Revenue
  • BRO $4,712,000,000.00
  • ALC $9,911,000,000.00
  • Revenue This Year
  • BRO $11.95
  • ALC $6.19
  • Revenue Next Year
  • BRO $8.36
  • ALC $7.00
  • P/E Ratio
  • BRO $33.88
  • ALC $44.71
  • Revenue Growth
  • BRO 12.06
  • ALC 4.82
  • 52 Week Low
  • BRO $80.87
  • ALC $77.54
  • 52 Week High
  • BRO $125.68
  • ALC $101.10
  • Technical
  • Relative Strength Index (RSI)
  • BRO 46.92
  • ALC 54.96
  • Support Level
  • BRO $109.97
  • ALC $80.48
  • Resistance Level
  • BRO $121.70
  • ALC $92.96
  • Average True Range (ATR)
  • BRO 3.86
  • ALC 2.72
  • MACD
  • BRO -0.39
  • ALC 0.38
  • Stochastic Oscillator
  • BRO 47.97
  • ALC 82.72

About BRO Brown & Brown Inc.

Brown & Brown Inc is an insurance agent and broker that offers insurance products and services, primarily in the areas of property, casualty, and employee benefits, by connecting customers with insurance companies. It earns its revenue via commissions from insurance companies and direct fees from customers, and it generally has no underwriting risk exposure. More than half of its revenue is from its retail segment, which provides a broad range of insurance products and services to entities and individuals. Roughly a fourth of revenue is from its national programs segment, which provides, among other things, professional liability coverage for professionals. The company operates primarily in the United States, with its highest exposure in Florida.

About ALC Alcon Inc.

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

Share on Social Networks: